Showing results (31-40 of 36) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The Lancet. Infectious Diseases|May 10, 2012
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trialPeter C Richmond, Helen S Marshall, Michael D Nissen, et al.Journal of the Pediatric Infectious Diseases Society|September 26, 2015
Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy AdolescentsTimo Vesikari, Lars Østergaard, Javier Diez-Domingo, et al.The New England Journal of Medicine|December 14, 2017
A Bivalent Meningococcal B Vaccine in Adolescents and Young AdultsLars Ostergaard, Timo Vesikari, Judith Absalon, et al.Vaccine|February 10, 2009
Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharideLisa K McNeil, Ellen Murphy, Xiao-Juan Zhao, et al.Vaccine|July 13, 2010
Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal diseaseHan-Qing Jiang, Susan K Hoiseth, Shannon L Harris, et al.Mbio|March 15, 2018
Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic VaccineLisa K McNeil, Robert G K Donald, Alexey Gribenko, et al.Pageof 4